FDA Approvals

Date Posted
Article Title
11/11/2011
FDA Approves First Umbilical Cord Blood Product

Hemacord stem cell product sanctioned for certain blood cancers and related disorders

11/7/2011
Erbitux Approval Expanded to Include Head and Neck Cancer

Most common in men, people older than 50

11/4/2011
Xarelto Approved to Prevent Stroke in People With Abnormal Heartbeat

Atrial fibrillation affects more than 2 million Americans

11/3/2011
11/2/2011
Device Approved to Remedy Abdominal Aneurysms

In people with smaller arteries

11/2/2011
MelaFind Device Approved to Detect Melanoma

A deadly form of skin cancer

10/31/2011
Exparel Approved for Post-Surgery Pain

Provides relief up to 72 hours

10/24/2011
First Versions of Generic Zyprexa Approved

To treat schizophrenia or bipolar disorder

10/24/2011
Onfi Approved to Treat Severe Seizures

When combined with other anti-seizure medication

10/14/2011
Ferriprox Approved to Treat 'Iron Overload'

A potential problem among people who get frequent blood transfusions

10/7/2011
Juvisync Approved for Type 2 Diabetics With High Cholesterol

Previously approved meds combined in one tablet

10/7/2011
Cialis Approved to Treat Enlarged Prostate

Also approved for treatment of BPH and erectile dysfunction occurring simultaneously

10/4/2011
'LeGoo' Vessel Plug Approved for Vascular Surgery

Dissolvable gel stems blood flow while joining vessels

9/28/2011
Child Face Mask Approved to Help Prevent Spread of Germs

In hospitals and other health care settings

9/26/2011
9/23/2011
9/19/2011
FDA OKs Bone Drug to Prevent Fracture in Certain Cancer Patients

Prolia can be used in some cases of prostate cancer and breast cancer

9/2/2011
Flu Diagnostic Kit Approved

Developed by the CDC

8/29/2011
Xalkori Approved for Advanced Lung Cancer

Therapy targets abnormal gene

8/26/2011
Extended-release Painkiller Approved

Nucynta ER sanctioned for chronic pain in adults